Federal Circuit Affirms Injunction, Wait Period To Market Biosimilar Drug
WASHINGTON, D.C. — A Florida federal judge properly awarded Amgen Inc. a preliminary injunction barring Apotex Inc. from entering the market for 180 days after receiving a requested license from the...To view the full article, register now.
Already a subscriber? Click here to view full article